Beijing has vehemently opposed the United States‘ recent imposition of a 10 percent additional tariff on Chinese imports, which was announced on February 1, Eastern Standard Time. The measure has been linked to the fentanyl issue, a justification that China has firmly rejected.
A statement from the Chinese Foreign Ministry expressed deep disapproval and strong opposition to the decision, emphasizing that necessary countermeasures would be taken to safeguard its legitimate rights and interests.
It was asserted that unilateral tariff increases fail to address domestic challenges in the U.S. and are inconsistent with global trade regulations.
China’s stance on trade matters has remained steadfast. The country has emphasized the adverse consequences of trade and tariff wars, arguing that such unilateral actions severely violate the World Trade Organization (WTO) rules.
Furthermore, it has underscored the ineffectiveness of tariffs in solving economic and social problems in the U.S. and the broader negative implications for global trade stability.
China’s record on counternarcotics policies and enforcement was highlighted as one of the toughest in the world. The fentanyl issue, it was stated, remains a challenge primarily for the U.S., and China has extended support in response to American concerns.
A significant step was taken in 2019 when China became the first nation to officially schedule fentanyl-related substances as a class, following a request from the U.S. Extensive cooperation between the two countries on counternarcotics efforts has been noted, with achievements considered evident.
Concerns have been raised regarding the potential impact of additional tariffs on ongoing bilateral counternarcotics cooperation. The U.S. was urged to adopt an objective and rational approach to addressing its fentanyl crisis rather than resorting to economic pressure tactics. Such actions are counterproductive and could jeopardize collaborative efforts in the future.
China has urged a corrective action, including appealing the tariff decision. The preservation also emphasizes preserving counternarcotics collaboration and promoting active and sustainable China-U.S. relationships.
